Success Metrics

Clinical Success Rate
86.8%

Based on 59 completed trials

Completion Rate
87%(59/68)
Active Trials
5(5%)
Results Posted
44%(26 trials)
Terminated
9(9%)

Phase Distribution

Ph phase_2
13
14%
Ph phase_3
6
6%
Ph early_phase_1
1
1%
Ph phase_4
38
40%
Ph phase_1
21
22%
Ph not_applicable
14
15%

Phase Distribution

22

Early Stage

13

Mid Stage

44

Late Stage

Phase Distribution93 total trials
Early Phase 1First-in-human
1(1.1%)
Phase 1Safety & dosage
21(22.6%)
Phase 2Efficacy & side effects
13(14.0%)
Phase 3Large-scale testing
6(6.5%)
Phase 4Post-market surveillance
38(40.9%)
N/ANon-phased studies
14(15.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.6%

59 of 76 finished

Non-Completion Rate

22.4%

17 ended early

Currently Active

5

trials recruiting

Total Trials

96

all time

Status Distribution
Active(7)
Completed(59)
Terminated(17)
Other(13)

Detailed Status

Completed59
unknown13
Terminated9
Withdrawn8
Recruiting3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
96
Active
5
Success Rate
86.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.1%)
Phase 121 (22.6%)
Phase 213 (14.0%)
Phase 36 (6.5%)
Phase 438 (40.9%)
N/A14 (15.1%)

Trials by Status

active_not_recruiting22%
recruiting33%
completed5961%
terminated99%
unknown1314%
not_yet_recruiting11%
enrolling_by_invitation11%
withdrawn88%

Recent Activity

Clinical Trials (96)

Showing 20 of 96 trialsScroll for more
NCT07568574Not Applicable

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling By Invitation
NCT06686628Phase 1

An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates

Completed
NCT05891119Early Phase 1

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

Completed
NCT05741385Not Applicable

A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Completed
NCT05631730Phase 3

Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse

Recruiting
NCT03519906

Bariatric Surgery and Pharmacokinetics of Metoprolol

Recruiting
NCT06808802Phase 1

To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants

Completed
NCT05031520

PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease

Terminated
NCT03566667Phase 4

Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease

Active Not Recruiting
NCT01585623Phase 1

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

Completed
NCT03556592Phase 1

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Completed
NCT06569212Phase 4

Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)

Recruiting
NCT01157234Phase 4

Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients

Completed
NCT03689946Phase 3

Effect of Evolocumab on Coronary Atherosclerosis

Completed
NCT02123056Phase 4

Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects

Active Not Recruiting
NCT06357104Phase 4

Detoxification From the Lipid Tract

Completed
NCT06035978Phase 4

Determination of Drug Levels for Pharmacotherapy of Heart Failure

Not Yet Recruiting
NCT00642434Phase 4

Comparison of Blood Pressure Medications on Metabolism

Completed
NCT02484859Phase 4

Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery

Completed
NCT04133532Phase 4

Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
96